Norbrook Laboratories Receives FDA Approval For Hexasol Injection

Norbrook Laboratories Ltd. announced the introduction of Hexasol Injection, which combines the long-acting antibiotic oxytetracycline (active ingredient in Noromycin 300 LA and 300 PRO LA) and the non-steroidal anti-inflammatory drug (NSAID) flunixin meglumine in one convenient dose. 

Hexasol Injection is indicated for the treatment of bacterial pneumonia associated with Pasteurella spp. and for the control of associated pyrexia (fever) in beef and non-lactating dairy cattle.

The duel-action formulation of Hexasol Injection offers veterinarians and cattle producers "a practical choice when combined antibiotic and antipyretic action is indicated," the company says. Key attributes of Hexasol Injection include "proven safe and effective ingredients, the convenience of a SQ or IM dosing option and a relatively short withdrawal time prior to slaughter of 21 days." 

Hexasol Injection is available by prescription only. 

Source: Norbrook Laboratories news release

1. Vilsack: Taking time to remember the fallen
2. Ag markets diverge just before the long holiday weekend
3. Study suggests dairy herd water quality linked to milk production
4. Wis. lawmakers question challenges to large wells
5. Traders evening up positions ahead of the weekend Friday
6. Bio-Vet and Keller break ground on new facility

1. Commentary: Milk faces branding dilemma
2. Salma Hayek: Milk part of 'perfect' breakfast
3. 4 rules for growing a business or industry
4. Chocolate milk a top post-workout food
5. Seven jobs more dangerous than farming
6. What do dairy exports mean for Minnesota?

1. Seven jobs more dangerous than farming
2. White House urges Senate to cut crop insurance in farm bill
3. Class III futures close out quietly last week
4. 4 rules for growing a business or industry
5. Drop in U.S. underground water levels has accelerated
6. Ongoing wave of Calif. metal theft prompts further legislation